BriaCell Therapeutics

(TSX) BCT

Current Price$5.73

Market Cap$41.55M

Since IPO (2014)-100%

5 YearN/A

1 Year-87%

1 Month-6%

BriaCell Therapeutics Financials at a Glance

Market Cap

$41.55M

Revenue (TTM)

$0.00

Net Income (TTM)

$43.11M

EPS (TTM)

$-38.83

P/E Ratio

-0.15

Dividend

$0.00

Beta (Volatility)

1.07 (Average)

Dividend

$0.00

Beta (Volatility)

1.07 (Average)

Price

$5.73

Volume

3,841

Open

$5.56

Price

$5.73

Volume

3,841

Open

$5.56

Previous Close

$5.73

Daily Range

$5.56 - $5.76

52-Week Range

$4.95 - $51.50

Dividend

$0.00

Beta (Volatility)

1.07 (Average)

Price

$5.73

Volume

3,841

Open

$5.56

Previous Close

$5.73

Daily Range

$5.56 - $5.76

52-Week Range

$4.95 - $51.50

BCT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BriaCell Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

William V. Williams, MD

Website

www.briacell.com

Headquarters

West Vancouver, BC V7T 2X1, CA

BCT Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-175%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

-6.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$41.55M

Shares Outstanding

7.25M

Volume

3.84K

Avg. Volume

16.62K

Financials (TTM)

Gross Profit

$147.89K

Operating Income

$37.73M

EBITDA

$36.63M

Operating Cash Flow

$28.17M

Capital Expenditure

$3.10

Free Cash Flow

$28.17M

Cash & ST Invst.

$17.87M

Total Debt

$0.00

BriaCell Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$27.08K

N/A

Gross Margin

0.00%

N/A

Market Cap

$41.55M

N/A

Market Cap/Employee

$2.60M

N/A

Employees

N/A

Net Income

$7.34M

-16.6%

EBITDA

$7.62M

-6.7%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$29.65M

+491.5%

Accounts Receivable

$2.26M

+5.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.29%

N/A

Return on Invested Capital

-1.24%

N/A

Free Cash Flow

$8.09M

-36.7%

Operating Cash Flow

$8.09M

-36.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MBX.TOMicrobix Biosystems Inc.

MBX.TOMicrobix Biosystems Inc.$0.25+0.00%

RVX.TOResverlogix Corp.

RVX.TOResverlogix Corp.$0.10+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.62+0.08%

IRENIren

IRENIren$61.20+0.08%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.28+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.57-0.07%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.35+0.01%

OPENOpendoor Technologies

OPENOpendoor Technologies$5.01-0.06%

Questions About BCT

What is the current price of BriaCell Therapeutics?

BriaCell Therapeutics is trading at CA$5.73 per share.

What is the 52-week range for BriaCell Therapeutics?

Over the past 52 weeks, BriaCell Therapeutics has traded between CA$4.95 and CA$51.50.

How much debt does BriaCell Therapeutics have?

As of the most recent reporting period, BriaCell Therapeutics reported total debt of N/A.

How much cash does BriaCell Therapeutics have on hand?

BriaCell Therapeutics reported $40.49M in cash and cash equivalents in its most recent financial results.

What is BriaCell Therapeutics’s dividend yield?

BriaCell Therapeutics does not currently have a dividend yield.

BriaCell Therapeutics

BriaCell Therapeutics Financials at a Glance

BCT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About BriaCell Therapeutics

BCT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

BriaCell Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BCT

What is the current price of BriaCell Therapeutics?

What is the 52-week range for BriaCell Therapeutics?

How much debt does BriaCell Therapeutics have?

How much cash does BriaCell Therapeutics have on hand?

What is BriaCell Therapeutics’s dividend yield?

Premium Investing Services